Renwik Bioinnovations Private Limited
Founded in 2019 and headquartered in Delhi, India.
2019 | Delhi (India) | Active
Renwik Bioinnovations Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.80 M
- Revenue Growth 48.99%
- Profit Growth -21.32%
- Ebitda 25.51%
- Net Worth 21.07%
- Total Assets 82.98%
About Renwik Bioinnovations
Renwik Bioinnovations Private Limited (RBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 28 November 2019 (Five years and three months 1 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.80 M.
Chandan Kumar and Vikash Kumar serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U73200DL2019PTC358147
- Company No.
358147
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Nov 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Trading
Who are the key members and board of directors at Renwik Bioinnovations?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandan Kumar  | Director | 28-Nov-2019 | Current |
| Vikash Kumar | Director | 26-Mar-2022 | Current |
Financial Performance of Renwik Bioinnovations.
Renwik Bioinnovations Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 48.99% increase. The company also saw a substantial fall in profitability, with a 21.32% decrease in profit. The company's net worth Soared by an impressive increase of 21.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Renwik Bioinnovations?
Unlock access to Renwik Bioinnovations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
Open Charges
₹0.80 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Dec 2022 | Canara Bank | ₹0.80 M | Open |
How Many Employees Work at Renwik Bioinnovations?
Unlock and access historical data on people associated with Renwik Bioinnovations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Renwik Bioinnovations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Renwik Bioinnovations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
